What one share of Iridex holds
IRIDEX Corporation (“IRIDEX”) is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases.
Iridex’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-04; the balance sheet is as of 2026-07-04.
| Sales | $2.99 |
|---|---|
| Profit | −$0.21 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$0.12 |
| Cash and investments | $0.27 |
| Debt | $0.22 |
| Book value | $0.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $3.12 | $0.26 | $0.02 | $0.28 | — | $1.70 |
| 2010 | $3.19 | $0.30 | $0.02 | $0.09 | — | $2.16 |
| 2011 | $3.24 | $0.26 | $0.02 | $0.20 | — | $2.51 |
| 2012 | $3.79 | $0.16 | $0.04 | −$0.17 | — | $2.59 |
| 2013 | $3.79 | $0.22 | $0.04 | $0.04 | — | $2.61 |
| 2014 | $4.13 | $0.97 | $0.05 | $0.33 | — | $3.45 |
| 2015 | $4.12 | $0.05 | $0.09 | −$0.14 | — | $3.37 |
| 2016 | $4.54 | −$1.15 | $0.10 | −$0.12 | — | $3.46 |
| 2017 | $3.60 | −$1.11 | $0.05 | −$0.36 | — | $2.63 |
| 2018 | $3.49 | −$1.05 | $0.04 | −$0.86 | — | $2.20 |
| 2019 | $3.17 | −$0.64 | $0.01 | −$0.59 | — | $1.65 |
| 2020 | $2.63 | −$0.46 | $0.01 | −$0.24 | — | $1.25 |
| 2021 | $3.50 | −$0.34 | $0.01 | $0.52 | — | $1.47 |
| 2022 | $3.57 | −$0.47 | $0.02 | −$0.62 | — | $1.08 |
| 2023 | $3.22 | −$0.59 | $0.01 | −$0.42 | — | $0.59 |
| 2024 | $2.96 | −$0.54 | $0.00 | −$0.44 | — | $0.13 |
| 2025 | $3.11 | −$0.26 | $0.01 | −$0.13 | — | $0.28 |
Common questions about Iridex
How much does one share of Iridex earn?
Over the last 12 months, Iridex lost $0.21 for each share on $2.99 of sales.
Does Iridex pay a dividend?
Iridex didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Iridex’s book value per share?
Iridex’s book value is $0.21 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of July 4, 2026.
How much cash and debt does each share of Iridex have?
Each share of Iridex has $0.27 of cash and investments and $0.22 of debt, as of July 4, 2026.
What is Iridex’s free cash flow per share?
−$0.12 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Iridex bought back shares?
Iridex’s share count rose about 70% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.